
AstraZeneca Pharma receives CDSCO nod for expanded use of Fasenra in India
AstraZeneca Pharma India Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute Benralizumab (brand name: Fasenra) in India for an additional medical indication. The newly approved indication …